Published in Gastroenterology on May 11, 2013
Volumetric Laser Endomicroscopy With Intelligent Real-time Image Segmentation (IRIS) | NCT03814824
Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis. Nat Genet (2014) 3.75
ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus. Am J Gastroenterol (2015) 3.22
Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma. Nat Genet (2015) 1.89
Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett's esophagus: a multi-center case-control study. PLoS Med (2015) 1.74
Yield of Repeat Endoscopy in Barrett's Esophagus with No Dysplasia and Low-Grade Dysplasia: A Population-Based Study. Dig Dis Sci (2015) 1.43
A randomized comparative effectiveness trial of novel endoscopic techniques and approaches for Barrett's esophagus screening in the community. Am J Gastroenterol (2014) 1.35
Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus. Cancer Prev Res (Phila) (2013) 1.31
BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol (2015) 1.17
Screening for Barrett's Esophagus. Gastroenterology (2015) 1.11
Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling. Cancer Epidemiol Biomarkers Prev (2014) 1.07
Implementation of new knowledge, technique, and technology to survey Barrett's is urgently needed. Gastroenterology (2013) 1.06
Esophageal cancer: Recent advances in screening, targeted therapy, and management. J Carcinog (2014) 1.02
Quality Indicators for the Management of Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma: International Consensus Recommendations from the American Gastroenterological Association Symposium. Gastroenterology (2015) 1.01
Garlic, silver bullets, and surveillance upper endoscopy for Barrett's esophagus. Gastroenterology (2013) 0.97
Alcohol and the risk of Barrett's esophagus: a pooled analysis from the International BEACON Consortium. Am J Gastroenterol (2014) 0.93
Biomarkers for dysplastic Barrett's: ready for prime time? World J Surg (2015) 0.89
Precision prevention of oesophageal adenocarcinoma. Nat Rev Gastroenterol Hepatol (2015) 0.88
In Barrett's esophagus patients and Barrett's cell lines, ursodeoxycholic acid increases antioxidant expression and prevents DNA damage by bile acids. Am J Physiol Gastrointest Liver Physiol (2014) 0.87
Evidence-based endoscopic management of Barrett's esophagus. Gastroenterol Rep (Oxf) (2014) 0.84
The Presence of Genetic Mutations at Key Loci Predicts Progression to Esophageal Adenocarcinoma in Barrett's Esophagus. Am J Gastroenterol (2015) 0.83
The Impact of a Prior Diagnosis of Barrett's Esophagus on Esophageal Adenocarcinoma Survival. Am J Gastroenterol (2017) 0.82
Barrett's esophagus and cancer risk: how research advances can impact clinical practice. Gut Liver (2014) 0.82
Research advances in esophageal diseases: bench to bedside. F1000Prime Rep (2013) 0.82
MicroRNAs in Barrett's esophagus: future prospects. Front Genet (2014) 0.82
The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus. Gut (2014) 0.82
Magnitude of Missed Esophageal Adenocarcinoma After Barrett's Esophagus Diagnosis: A Systematic Review and Meta-analysis. Gastroenterology (2015) 0.81
Screening for Barrett's esophagus and esophageal adenocarcinoma: rationale, recent progress, challenges, and future directions. Clin Gastroenterol Hepatol (2014) 0.81
From genomics to diagnostics of esophageal adenocarcinoma. Nat Genet (2014) 0.79
Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett's esophagus cohort. Gastrointest Endosc (2016) 0.77
Barrett oesophagus in 2013: risk stratification and surveillance in Barrett oesophagus. Nat Rev Gastroenterol Hepatol (2013) 0.77
Barrett's esophagus in 2016: From pathophysiology to treatment. World J Gastrointest Pharmacol Ther (2016) 0.76
Gastrin stimulates a cholecystokinin-2-receptor-expressing cardia progenitor cell and promotes progression of Barrett's-like esophagus. Oncotarget (2017) 0.76
Surveillance in Patients With Barrett's Esophagus for Early Detection of Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis. Clin Transl Gastroenterol (2015) 0.76
Surveillance in Barrett esophagus. J Med Life (2014) 0.75
Premature Birth and Large for Gestational Age Are Associated with Risk of Barrett's Esophagus in Adults. Dig Dis Sci (2015) 0.75
Cost-effectiveness of chemoprevention with proton pump inhibitors in Barrett's esophagus. Dig Dis Sci (2014) 0.75
Barrett's Esophagus: Diagnosis and Management. Gastrointest Endosc (2017) 0.75
Recent developments in pathogenesis, diagnosis and therapy of Barrett's esophagus. World J Gastroenterol (2015) 0.75
Endoscopic surveillance of gastrointestinal premalignant lesions: current knowledge and future directions. Curr Opin Gastroenterol (2014) 0.75
Genetic progression of Barrett's oesophagus to oesophageal adenocarcinoma. Br J Cancer (2016) 0.75
Reply: To PMID 23673354. Gastroenterology (2013) 0.75
Improved specimen adequacy using jumbo biopsy forceps in patients with Barrett's esophagus. World J Gastroenterol (2015) 0.75
Ineffective surveillance does not improve survival in patients with Barrett's who progress to adenocarcinoma. Gastroenterology (2013) 0.75
Editorial: The Effect of Bias on Estimation of Improved Survival After Diagnosis of Barrett's Esophagus. Am J Gastroenterol (2017) 0.75
Endoscopic Treatment Versus Esophagectomy for Early-Stage Esophageal Cancer: a Population-Based Study Using Propensity Score Matching. J Gastrointest Surg (2017) 0.75
Diagnosis and Surveillance of Barrett's Esophagus: Addressing the Transatlantic Divide. Dig Dis Sci (2016) 0.75
Advances in the Diagnosis and Treatment of Barrett's Esophagus and Early Esophageal Cancer; Summary of the Kelly and Carlos Pellegrini SSAT/SAGES Luncheon Symposium. J Gastrointest Surg (2017) 0.75
Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health (1992) 20.06
Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet (2010) 15.50
A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med (1992) 10.70
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA (2011) 9.13
Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med (2011) 8.62
Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol (2008) 7.94
Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet (2006) 6.78
Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA (2011) 6.45
American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology (2011) 5.93
Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study. Lancet (1984) 5.87
Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology (2001) 5.80
A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med (2009) 4.51
Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology (1993) 4.23
Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study. BMJ (2000) 4.21
Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology (2007) 3.94
Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2009) 3.66
A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology (2004) 3.50
Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Ann Intern Med (2003) 3.30
Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology (2002) 3.28
Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut (1996) 2.75
Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut (1998) 2.38
Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg (1994) 2.25
Endoscopic surveillance of Barrett's esophagus. Does it help? J Thorac Cardiovasc Surg (1993) 2.00
Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans. Gastrointest Endosc (2008) 1.96
Effect of race and socioeconomic status in the treatment of appendicitis in patients with equal health care access. Arch Surg (2011) 1.77
Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol (2003) 1.70
Diagnosing Barrett's esophagus: reliability of clinical and pathologic diagnoses. Gastrointest Endosc (2009) 1.68
Barrett's esophagus: a retrospective analysis of 13 years surveillance. J Gastroenterol Hepatol (2008) 1.63
Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care. J Gen Intern Med (2009) 1.63
Mortality in Barrett's oesophagus: results from a population based study. Gut (2003) 1.60
A majority of patients with Barrett's oesophagus are unlikely to benefit from endoscopic cancer surveillance. Eur J Gastroenterol Hepatol (2001) 1.52
Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer (2002) 1.48
Does screening for Barrett's esophagus and adenocarcinoma of the esophagus prolong survival? J Clin Oncol (2005) 1.40
Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus. Am J Gastroenterol (2000) 1.25
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling. Health Technol Assess (2006) 1.21
Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus. Surg Endosc (2001) 1.21
A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women. Cancer Causes Control (2008) 1.05
Barrett's esophagus: Incidence, etiology, pathophysiology, prevention and treatment. Ther Clin Risk Manag (2007) 1.00
Is endoscopic surveillance for non-dysplastic Barrett's esophagus cost-effective? Review of economic evaluations. J Gastroenterol Hepatol (2011) 0.96
Barrett's surveillance is worthwhile and detects curable cancers. A prospective cohort study addressing cancer incidence, treatment outcome and survival. Eur J Gastroenterol Hepatol (2005) 0.94
Long-term survival and cost analysis of an annual Barrett's surveillance programme. Eur J Gastroenterol Hepatol (2010) 0.86
SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish and humans. Science (2005) 12.02
Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA (2003) 7.42
Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med (2014) 6.54
Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux. Science (2010) 6.04
Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med (2013) 5.38
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet (2009) 5.13
Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med (2006) 5.10
Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol (2010) 4.94
Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet (2012) 4.73
Potential for conflict of interest in the evaluation of suspected adverse drug reactions: use of cerivastatin and risk of rhabdomyolysis. JAMA (2004) 4.71
GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science (2013) 4.71
Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA (2011) 4.70
Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA (2013) 4.67
Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet (2008) 4.17
Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol (2005) 4.04
Outcomes of planned home births in Washington State: 1989-1996. Obstet Gynecol (2002) 3.99
Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology (2007) 3.94
Gramene: a resource for comparative grass genomics. Nucleic Acids Res (2002) 3.72
Gramene: a bird's eye view of cereal genomes. Nucleic Acids Res (2006) 3.47
Predictive value of symptoms for early detection of ovarian cancer. J Natl Cancer Inst (2010) 3.42
Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem (2006) 3.40
Exploring the temperature-stress metabolome of Arabidopsis. Plant Physiol (2004) 3.30
Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology (2002) 3.28
Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet (2008) 3.23
Genome sequencing reveals insights into physiology and longevity of the naked mole rat. Nature (2011) 3.19
Gramene, a tool for grass genomics. Plant Physiol (2002) 3.14
Hormone replacement therapy in relation to breast cancer. JAMA (2002) 3.14
Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst (2005) 3.06
Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA (2003) 3.04
The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection. Hepatology (2013) 2.98
Life After Cancer Epidemiology (LACE) Study: a cohort of early stage breast cancer survivors (United States). Cancer Causes Control (2005) 2.94
Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol (2005) 2.92
Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1. Nat Immunol (2008) 2.89
Randomized trial of light versus deep sedation on mental health after critical illness. Crit Care Med (2009) 2.83
Risk of HIV-1 in rural Kenya: a comparison of circumcised and uncircumcised men. Epidemiology (2004) 2.82
Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care (2008) 2.76
Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial. JAMA (2008) 2.76
A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol (2011) 2.75
A comparison between audio computer-assisted self-interviews and clinician interviews for obtaining the sexual history. Sex Transm Dis (2004) 2.62
Menopausal hormone therapy and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2007) 2.55
25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis (2007) 2.40
Parathyroidectomy rates among United States dialysis patients: 1990-1999. Kidney Int (2004) 2.37
Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med (2008) 2.33
Next generation genome-wide association tool: design and coverage of a high-throughput European-optimized SNP array. Genomics (2011) 2.31
Recent trials in hypertension: compelling science or commercial speech? JAMA (2006) 2.30
Comparative analysis of bat genomes provides insight into the evolution of flight and immunity. Science (2012) 2.29
Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut (2006) 2.28
A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. Crit Care Med (2011) 2.27
BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res (2003) 2.27
Management guided by brain tissue oxygen monitoring and outcome following severe traumatic brain injury. J Neurosurg (2009) 2.21
Male circumcision in Siaya and Bondo Districts, Kenya: prospective cohort study to assess behavioral disinhibition following circumcision. J Acquir Immune Defic Syndr (2007) 2.21
Incidence of suicide in persons with cancer. J Clin Oncol (2008) 2.21
Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer (2003) 2.20
Effect of acute lung injury and acute respiratory distress syndrome on outcome in critically ill trauma patients. Crit Care Med (2004) 2.20
Dietary phosphorus is associated with greater left ventricular mass. Kidney Int (2013) 2.19
Gramene: development and integration of trait and gene ontologies for rice. Comp Funct Genomics (2002) 2.16
Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med (2013) 2.15
Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis. Nat Genet (2012) 2.14
Meta-analysis of effectiveness of first-generation drug-eluting stents versus coronary artery bypass grafting for unprotected left main coronary disease. Am J Cardiol (2012) 2.07
Mutations of PIK3CA in gastric adenocarcinoma. BMC Cancer (2005) 2.06
Tradeoffs between accuracy measures for electronic health care data algorithms. J Clin Epidemiol (2011) 2.06
Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables. J Clin Oncol (2010) 2.04
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus. Arch Intern Med (2008) 2.01
Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells. Proc Natl Acad Sci U S A (2011) 2.01
Reporting participation in case-control studies. Epidemiology (2002) 1.99
Iron deficiency and gastrointestinal malignancy: a population-based cohort study. Am J Med (2002) 1.96
Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts. Proc Natl Acad Sci U S A (2012) 1.94
Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev (2008) 1.89
Limitations of basing screening policies on screening trials: The US Preventive Services Task Force and Prostate Cancer Screening. Med Care (2013) 1.88
Human FcγRIIA induces anaphylactic and allergic reactions. Blood (2011) 1.86
Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B. Clin Gastroenterol Hepatol (2012) 1.84
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
Computational aeroacoustics of phonation, part II: Effects of flow parameters and ventricular folds. J Acoust Soc Am (2002) 1.82
Risk of hip fracture among dialysis and renal transplant recipients. JAMA (2002) 1.81
The prevalence of knee pain and symptomatic knee osteoarthritis among veteran traumatic amputees and nonamputees. Arch Phys Med Rehabil (2005) 1.81
Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors. Cancer Res (2010) 1.80
Microbial biodegradation of polyaromatic hydrocarbons. FEMS Microbiol Rev (2008) 1.80
SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production. Immunity (2006) 1.79
Environment or host?: A case-control study of risk factors for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med (2012) 1.78
Incidence of primary urethral carcinoma in the United States. Urology (2006) 1.78
Trends in treatment of advanced epithelial ovarian cancer in the Medicare population. Gynecol Oncol (2011) 1.77
Association between serum uric acid level and chronic liver disease in the United States. Hepatology (2010) 1.76
Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease. J Neurosci (2008) 1.75
Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J Clin Invest (2007) 1.74
Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients. J Acquir Immune Defic Syndr (2010) 1.74
The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. Gastroenterology (2004) 1.74
Colonization of the Tibetan Plateau by the homoploid hybrid pine Pinus densata. Mol Ecol (2011) 1.74
Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism (2009) 1.73
New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol (2009) 1.72
Functional outcomes in pediatric severe sepsis: further analysis of the researching severe sepsis and organ dysfunction in children: a global perspective trial. Pediatr Crit Care Med (2013) 1.70
Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. JAMA (2004) 1.70
Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev (2005) 1.68
Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy. Am J Epidemiol (2012) 1.68
A novel glucose ENFET based on the special reactivity of MnO2 nanoparticles. Biosens Bioelectron (2004) 1.68
Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol (2012) 1.65